Delivery Order SPE2DH25D0001-SPE2D425F712D
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,332.50 on July 15, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, calls for the delivery of EG7+ cartridge medical products to the place of performance in North Chicago, Illinois, with an ultimate completion date of July 17, 2025. This award represents a child...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,472.50 by the Medical Supply Chain division of the Department of Defense on August 29, 2025, with an ultimate completion date of September 3, 2025. The contract, designated as 4569273740 for a CG8+ Cartridge, utilizes fixed-price pricing with economic price adjustment terms and will be performed in North Chicago, Illinois. This delivery order represents a task order call against a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,041.75 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of September 12, 2025. The contract covers CG8+ cartridge products and is structured as a fixed-price delivery order with economic price adjustment provisions. The award was made on September 10, 2025, with no set-aside designation, indicating full and open competition. Performance...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on September 11, 2025, valued at $2,329.60 for the procurement of CG8+ cartridges. The contract, which utilizes fixed-price pricing with economic price adjustment mechanisms, is scheduled for completion by September 15, 2025, and will be performed in North Chicago, Illinois. The award was made without set-aside designation, indicating full and open competition. The funding federal agency is the...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,472.50 by the Department of Defense's Medical Supply Chain on September 5, 2025, with completion expected by September 9, 2025. The contract, designated as 4569345436 and classified as a fixed-price delivery order with economic price adjustment provisions, calls for the supply of CG8+ cartridges to support federal healthcare operations. The work will be performed at Abbott's facility in...
- Abbott Laboratories Inc., through its Abbott Point of Care division, received a delivery order award on September 11, 2025, valued at $1,646.25 for CG8+ cartridges from the Medical Supply Chain, a defense-focused federal agency. The contract employs fixed-price pricing with economic price adjustment mechanisms and will be performed in North Chicago, Illinois, with an ultimate completion date of September 15, 2025. No set-aside designation was used in this award, indicating full and open...
- Abbott Laboratories Inc., operating through its Abbott Point of Care division, was awarded a delivery order on September 10, 2025, for CG8+ cartridge supplies under a fixed-price contract with economic price adjustment provisions. The contract, valued at $1,268.96, is not set aside and represents a full and open competition award. The order is set to be completed by September 12, 2025, with performance taking place at Abbott's facility in North Chicago, Illinois. This delivery order is part of...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,104.75 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025, with completion expected by September 10, 2025. The contract covers CG8+ Cartridge products and utilizes fixed-price pricing with economic price adjustment terms. The award was made without a set-aside designation, indicating full and open competition. Performance of this delivery order will take place...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $4,839.00 by the Medical Supply Chain division of the Department of Defense on September 11, 2025, with an ultimate completion date of September 15, 2025. The contract, issued under a fixed-price structure with economic price adjustment provisions, covers the supply of CG8+ cartridges for medical diagnostic and point-of-care testing applications. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,041.15 on August 27, 2025, by the Defense or Civilian Medical Supply Chain agency, with a completion deadline of August 29, 2025. The contract covers the supply of CG8+ cartridges and is structured as a fixed-price delivery order with economic price adjustment provisions. The work will be performed at Abbott's facility in North Chicago, Illinois. This award was made through full and...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D425F712DDelivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on September 18, 2025, with a ceiling value of $1,166.25 for an EG7+ Cartridge under a fixed-price contract with economic price adjustment provisions. The delivery order has an ultimate completion date of September 22, 2025, and will be performed at Abbott's North Chicago, Illinois location. This award represents a child contract under a larger vehicle structure and was procured through full and open competition with no set-aside designation. The contract is funded by the Medical Supply Chain within the Defense sector, reflecting Abbott's ongoing role as a critical supplier of diagnostic and point-of-care testing equipment to federal healthcare systems. As a global healthcare company specializing in medical devices and diagnostics, Abbott Laboratories maintains an established presence in federal procurement markets, particularly through multiple Blanket Purchase Agreements with the Department of Veterans Affairs and General Services Administration schedules. The EG7+ Cartridge delivery aligns with the company's core business of supplying immunoassay and point-of-care diagnostic solutions to support federal medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/18/25 |